4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-020578
Chief Operations Officer sold 7,000 shares at $17.41 ($121,870)
- Chief Operations Officer acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Newell Joe · Chief Operations Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 1 in the form | +3,500 | $12.15 | $42,525 | 145,219 | D |
| 2021-03-15 | Sale : show line 2 in the form | −7,000 | $17.41 | $121,870 | 138,219 | D |
| Open-market sales · 7,000 sh · avg $17.41 · $121,870 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) | −2,791 | 43,250 | D |
| 2021-03-15 | Exercise or conversion : show line 4 in the form Employee Stock Option (Right to Buy) | −709 | 12,750 | D |
Loading xslF345X03/doc4.xml…